skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
Tetanus-CMV Fusion Peptide Vaccine (Code C78821)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Tetanus-CMV Fusion Peptide Vaccine

Definition: A vaccine containing an inactivated epitope of tetanus toxin fused to a cytomegalovirus (CMV) peptide epitope, with potential anti-viral and immunomodulating activities. Upon administration, tetanus-CMV fusion peptide may stimulate a cytotoxic T-lymphocyte (CTL) response against CMV in the CMV-infected host. Tetanus toxin contains universal T cell helper epitopes.

Display Name: Tetanus-CMV Fusion Peptide Vaccine

Label: Tetanus-CMV Fusion Peptide Vaccine

NCI Thesaurus Code: C78821 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: CL387743  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
Tetanus-CMV Fusion Peptide Vaccine

External Source Codes: 
PDQ Closed Trial Search ID 601198
PDQ Open Trial Search ID 601198 (check for NCI PDQ open clinical trial info)

Other Properties:
     Name Value (qualifiers indented underneath)
code C78821
Contributing_Source CTRP
Legacy_Concept_Name Tetanus-CMV_Fusion_Peptide_Vaccine
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom